# Bifidobacterium Longum Subspecies Infantis

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bifidobacterium-longum-subspecies-infantis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-15
**Evidence Score:** 6 / 10
**Category:** Fermented/Probiotic
**Also Known As:** Bifidobacterium longum subspecies infantis, B. infantis, Bifidobacterium infantis, Infant Bifidus

## Overview

Bifidobacterium longum subsp. infantis is a specialized probiotic bacterium that colonizes the infant gut by efficiently metabolizing human milk oligosaccharides (HMOs), producing beneficial short-chain fatty acids (SCFAs) and bacteriocins. This action helps establish a healthy [microbiome](/ingredients/condition/gut-health), modulate immune responses, and reduce systemic [inflammation](/ingredients/condition/inflammation).

## Health Benefits

- Establishes a healthy [gut microbiome](/ingredients/condition/gut-health) in infants by efficiently metabolizing human milk oligosaccharides (HMOs).
- Enhances [immune system](/ingredients/condition/immune-support) development and reduces the risk of infections in early life.
- Reduces systemic [inflammation](/ingredients/condition/inflammation) and supports regulatory immune balance through short-chain fatty acid (SCFA) production.
- Improves symptoms of irritable bowel syndrome (IBS), diarrhea, and gut permeability in adults.
- Promotes nutrient absorption and supports the uptake of essential vitamins and minerals.
- Protects against pathogenic bacteria and strengthens the gut barrier function.

## Mechanism of Action

B. infantis metabolizes human milk oligosaccharides (HMOs) via specific gene clusters encoding glycosyl hydrolases and ABC transporters, converting them into monosaccharides and beneficial short-chain fatty acids (SCFAs) like acetate and lactate. It also produces various bacteriocins (e.g., lanthipeptides, lasso peptides) that inhibit the growth of pathogenic bacteria, further supporting a healthy gut environment and [immune modulation](/ingredients/condition/immune-support).

## Clinical Summary

Extensive clinical studies, including randomized controlled trials in infants, consistently demonstrate the efficacy of B. infantis. These studies, often involving cohorts from birth, show its ability to establish a healthy infant [microbiome](/ingredients/condition/gut-health), program immune responses, and reduce [inflammatory](/ingredients/condition/inflammation) gastrointestinal conditions. Research also highlights its SCFA-mediated mechanisms in supporting overall gut health in both infant and adult populations.

## Nutritional Profile

- Live [Probiotic](/ingredients/condition/gut-health) Cultures: Bifidobacterium longum subsp. infantis (1-10 billion CFUs per serving)
- Short-Chain Fatty Acids (SCFAs): Acetate and butyrate, supporting gut epithelial health and anti-inflammatory responses.
- Human Milk Oligosaccharide (HMO) Metabolizers: Enzymes that break down complex oligosaccharides.
- [Immunomodulatory](/ingredients/condition/immune-support) Compounds: Activate T-regulatory cells and reduce [pro-inflammatory cytokine](/ingredients/condition/inflammation)s (e.g., IL-6, TNF-α).

## Dosage & Preparation

- Supplements: Available in capsule, powder, or liquid forms, often included in infant formulas and specialized probiotic blends.
- Dosage: Typically 1–10 billion CFUs (colony-forming units) daily, adjusted based on age, product formulation, and specific health needs.
- Pairing: Often co-administered with [prebiotic](/ingredients/condition/gut-health)s such as human milk oligosaccharides (HMOs) or galactooligosaccharides (GOS) for enhanced colonization and synergistic effects.
- Application: Suitable for infants, children, and adults to support foundational gut and immune resilience.

## Safety & Drug Interactions

Bifidobacterium longum subsp. infantis is generally recognized as safe (GRAS), particularly for infants due to its natural presence in the [gut microbiome](/ingredients/condition/gut-health). Side effects are rare and typically mild, such as temporary bloating or gas, especially when first introduced. No significant drug interactions have been widely reported, though caution is advised with immunocompromised individuals or those with central venous catheters. It is considered safe for use during pregnancy and lactation.

## Scientific Research

Extensive clinical studies support the efficacy of B. infantis in establishing a healthy infant [microbiome](/ingredients/condition/gut-health), programming immune responses, and reducing [inflammatory](/ingredients/condition/inflammation) gastrointestinal conditions. Research consistently documents its short-chain fatty acid (SCFA)-mediated mechanisms in both infant and adult health.

## Historical & Cultural Context

Bifidobacterium longum subsp. infantis has been a natural component of the microbiota in breastfed infants for millennia, playing an unacknowledged but critical role in foundational immune health. Its specific identification and therapeutic application are modern developments, extending its use across the lifespan for its profound [anti-inflammatory](/ingredients/condition/inflammation) and gut-stabilizing effects.

## Synergistic Combinations

Role: Prebiotic matrix
Intention: Gut & [Microbiome](/ingredients/condition/gut-health) | Immune & [Inflammation](/ingredients/condition/inflammation)
Primary Pairings: - Human Milk Oligosaccharides (HMOs)
- Galactooligosaccharides (GOS)
- Fructooligosaccharides (FOS)
- Vitamin D (Cholecalciferol)

## Frequently Asked Questions

### What is B. infantis?

B. infantis is a specialized probiotic bacterium that naturally colonizes the infant gut, particularly in breastfed infants. It is adept at thriving by efficiently metabolizing human milk oligosaccharides (HMOs) into beneficial compounds.

### How does B. infantis benefit infants?

It helps establish a healthy gut microbiome by utilizing HMOs, outcompeting harmful bacteria and producing short-chain fatty acids. This process supports immune system development, reduces inflammation, and lowers the risk of infections in early life.

### What are Human Milk Oligosaccharides (HMOs) and why are they important to B. infantis?

HMOs are complex sugars found in breast milk that act as prebiotics, selectively feeding beneficial bacteria like B. infantis. B. infantis has unique genetic machinery to break down HMOs, making it particularly well-suited to the infant gut environment and giving it a competitive advantage.

### Are there scientific studies supporting the use of B. infantis?

Yes, extensive clinical studies, including randomized controlled trials, support the efficacy of B. infantis in establishing a healthy infant microbiome. Research consistently demonstrates its role in shaping the infant microbiome, programming immune responses, and reducing inflammatory conditions.

### Is B. infantis safe for infants?

B. infantis is generally considered very safe for infants, given its natural presence in a healthy infant gut microbiome. Side effects are are and typically mild, such as temporary minor digestive upset, especially when first introduced.

### How much B. infantis should be given to infants, and how often?

Typical infant probiotic formulations contain 1–10 billion CFU (colony-forming units) of B. infantis per dose, though optimal dosing varies by product and age. Most clinical studies in infants used daily dosing, and it is generally safe to give continuously from birth or introduction without cycling on and off. Always follow the product label or pediatrician guidance, as dosage may depend on the infant's age, weight, and specific health condition being addressed.

### Can B. infantis be safely used alongside antibiotics in infants?

B. infantis can be used during and after antibiotic courses, as it may help restore healthy gut flora disrupted by antibiotics. However, it is best to administer B. infantis at least 2–3 hours apart from antibiotics to avoid direct antibiotic exposure that could reduce bacterial viability. Consult with a pediatrician before combining B. infantis with any medication to ensure optimal timing and safety.

### Which infants benefit most from B. infantis supplementation?

B. infantis is most beneficial for exclusively or predominantly breastfed infants, as they naturally consume HMOs in breast milk that B. infantis uniquely metabolizes. Infants experiencing colic, frequent infections, irregular digestion, or those born via cesarean section (which delays natural microbial colonization) may also see particular benefits. Formula-fed infants can benefit as well, though the advantage may be less pronounced since standard infant formula does not contain HMOs at the same levels as breast milk.

## References

Research links: https://www.ncbi.nlm.nih.gov/search/all/?term=Bifidobacterium+Longum+Subspecies+Infantis; https://fdc.nal.usda.gov/fdc-app.html#/search?query=Bifidobacterium+Longum+Subspecies+Infantis | Studies: https://pubmed.ncbi.nlm.nih.gov/?term=Bifidobacterium+Longum+Subspecies+Infantis

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*